Printer Friendly Version

Send to a Friend

Cambridge Major Laboratories (CML) will initiate a $30 million expansion of its active pharmaceutical ingredient (API) manufacturing site in Germantown, Wis., in June of 2008. The project will expand the existing 60,000-sf campus to create 180,000-sf of medium scale (3-5 metric tons) manufacturing capacity. Enabling CML to expand production capacity and clinical development services, the completed campus will be comprised of two production halls with a total of seven reactor suites; analytical and process R&D kilo labs; a solvent/waste tank farm and thermal oxidizer; offices; warehouse; and support. CML partners with pharmaceutical companies to provide more cost effective, large scale production of clinical candidates as compared to an in-house facility.